PROPHYLAXIS OF BLEEDING
Clinical trials for PROPHYLAXIS OF BLEEDING explained in plain language.
Never miss a new study
Get alerted when new PROPHYLAXIS OF BLEEDING trials appear
Sign up with your email to follow new studies for PROPHYLAXIS OF BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized dosing for hemophilia a: a smarter approach?
Disease control CompletedThis study tested a new scoring method to help doctors choose the best Jivi treatment plan for people with hemophilia A. 21 participants switched from standard factor VIII products to Jivi, and their dose frequency was tailored based on their risk of bleeding. The goal was to see…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
New hope for young hemophilia patients: safer, fewer injections on the horizon
Disease control CompletedThis study looked at the safety of BAY 94-9027 (Jivi) in 36 children aged 7 to 12 with severe hemophilia A. The medicine is a longer-lasting clotting factor given as an injection to prevent and treat bleeding. Researchers monitored for allergic reactions and whether the drug stop…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 04, 2026 16:20 UTC